Cheplapharm is a globally operating company headquartered in Germany, with an established sustainable platform investing worldwide in well-established pharmaceutical brands which have been developed and introduced by research-based pharmaceutical companies.

Our team offered multijurisdictional finance and tax advice. The proceeds from the issuance will be used to redeem and refinance existing notes. The refinancing extends Cheplapharm’s maturity profile and increases its financial flexibility.